Genetic Information as a Life Style Change Motivator (APOE4MOT)
Primary Purpose
Health Behavior, Alzheimer Disease, Protection Against
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
information on the risk gene status
life style advise
Sponsored by
About this trial
This is an interventional prevention trial for Health Behavior
Eligibility Criteria
Inclusion Criteria:
- Age between 40 and 60 years
- overall good health (no chronic conditions e.g. mental disorders, cancer, liver or kidney disease, current or previous diagnosis),
- body mass index (BMI) under 35 kg/m2,
- blood pressure under 140/90 mmHg (medication allowed),
- serum total cholesterol under 7.25 mmol/l (medication allowed)
- fasting plasma glucose level under 7 mmol/l.
Exclusion Criteria:
- Abnormal values of the alanine amino transferase, alkaline phosphatase, haptoglobin and thyroid stimulating hormone
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Active Comparator
Arm Label
Tervas
Informed
non informed
Arm Description
Follow up group from an earlier study. Information on risk gene status. All test persons were given information on healthy diet and life style.
Information on risk gene status was given before intervention. All test persons were given information on healthy diet and life style.
Information on risk gene status was not given before intervention. All test persons were given information on healthy diet and life style.
Outcomes
Primary Outcome Measures
Number of participants with good quality of dietary fat
A questionnaire according to Finnish guidelines of Suomen Sydänliitto ry, Helldán & Helakorpi, (2015)
Dietary habits, number of participants
A questionnaire asking for
Fish intake at least twice per week
Consumption of high fat and sugar foods
Consumption of vegetables
Alcohol consumption
Physical activity at least twice per week
Food choice questionnaire, health and taste attitude
Scale 1-7 (7 most important, fully agree)
Food involvement and Food mavenism, scale 1-5
5 fully agree
Health concern, scale 1-9
1 not concerned at all
Life-orientation test, scale 1-5
1 fully agree
Locus of Control, state-trait anxiety inventory, Three-Factor Eating Questionnaire (TFEQ) scale 1-4
4 fully agree
weight kg
height m
Waist circumference, cm
Visceral fat level (1-30)
blood pressure, mmHg
Serum lipid levels mmol/L
Blood glucose levels, mmol/L
Serum lipid peroxidation, MDA/µM
Serum Sensitive C reactive protein, mg/L
Serum Hemoglobin, g/L
Serum Alkaline phosphatase, U/L
Serum Alanine aminotransferase, U/L
Serum haptoglobin, g/L
Plasma thyrotropin, mU/L
serum APOE protein, mg/L
serum brain-derived neurotrophic factor, ng/ml
serum Fatty acids, g/100g fatty acids
serum Carotenoids, retinol and α-tocopherol, Plasma total phenolics ng/µl
Blood cell count
APOE and BDNF genotype
Secondary Outcome Measures
Body mass index
weight and height will be combined to report BMI in kg/m^2
Full Information
NCT ID
NCT03794141
First Posted
December 13, 2018
Last Updated
February 25, 2020
Sponsor
Natural Resources Institute Finland
Collaborators
University of Turku, University of Eastern Finland, Academy of Finland
1. Study Identification
Unique Protocol Identification Number
NCT03794141
Brief Title
Genetic Information as a Life Style Change Motivator
Acronym
APOE4MOT
Official Title
Effects of ApoE4 Genotype Information and Intervention Intensity on the Fulfillment of Lifestyle Changes and Sensory Preferences
Study Type
Interventional
2. Study Status
Record Verification Date
December 2018
Overall Recruitment Status
Completed
Study Start Date
January 2, 2017 (Actual)
Primary Completion Date
March 30, 2019 (Actual)
Study Completion Date
July 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Natural Resources Institute Finland
Collaborators
University of Turku, University of Eastern Finland, Academy of Finland
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The study investigates whether information on having a risk genotype (ApoE4) and life style advisory information affects lifestyle changes and sensory preferences. The project studies also the ethic aspects of giving the information of risk genotype.
Detailed Description
We will run intervention based on our earlier pilot study. It includes intensive intervention and a modification of our earlier pilot intervention. Our intervention methods are general lectures of the effects of healthy diet (Finnish Nutrition Recommendations 2014) and healthy lifestyle for all participants. Effects on motivation, attitudes and preferences will be studied and verified by questionnaires and risk factors of cardiovascular disease and Alzheimer disease by analyzing clinical markers of lipid metabolism, general phenotype markers and profiles of nutritional markers. Nutritional biomarkers will verify also the self-reported changes of diet in the questionnaires and in digital food diaries.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Health Behavior, Alzheimer Disease, Protection Against
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
333 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Tervas
Arm Type
Experimental
Arm Description
Follow up group from an earlier study. Information on risk gene status. All test persons were given information on healthy diet and life style.
Arm Title
Informed
Arm Type
Experimental
Arm Description
Information on risk gene status was given before intervention. All test persons were given information on healthy diet and life style.
Arm Title
non informed
Arm Type
Active Comparator
Arm Description
Information on risk gene status was not given before intervention. All test persons were given information on healthy diet and life style.
Intervention Type
Behavioral
Intervention Name(s)
information on the risk gene status
Intervention Description
information on risk gene status (APOE4 allele or not) was given before intervention
Intervention Type
Behavioral
Intervention Name(s)
life style advise
Intervention Description
all test persons were given information on healthy diet and life style
Primary Outcome Measure Information:
Title
Number of participants with good quality of dietary fat
Description
A questionnaire according to Finnish guidelines of Suomen Sydänliitto ry, Helldán & Helakorpi, (2015)
Time Frame
2 years
Title
Dietary habits, number of participants
Description
A questionnaire asking for
Fish intake at least twice per week
Consumption of high fat and sugar foods
Consumption of vegetables
Alcohol consumption
Physical activity at least twice per week
Time Frame
2 years
Title
Food choice questionnaire, health and taste attitude
Description
Scale 1-7 (7 most important, fully agree)
Time Frame
2 years
Title
Food involvement and Food mavenism, scale 1-5
Description
5 fully agree
Time Frame
2 years
Title
Health concern, scale 1-9
Description
1 not concerned at all
Time Frame
2 years
Title
Life-orientation test, scale 1-5
Description
1 fully agree
Time Frame
2 years
Title
Locus of Control, state-trait anxiety inventory, Three-Factor Eating Questionnaire (TFEQ) scale 1-4
Description
4 fully agree
Time Frame
2 years
Title
weight kg
Time Frame
2 years
Title
height m
Time Frame
2 years
Title
Waist circumference, cm
Time Frame
2 years
Title
Visceral fat level (1-30)
Time Frame
2 years
Title
blood pressure, mmHg
Time Frame
2 years
Title
Serum lipid levels mmol/L
Time Frame
2 years
Title
Blood glucose levels, mmol/L
Time Frame
2 years
Title
Serum lipid peroxidation, MDA/µM
Time Frame
2 years
Title
Serum Sensitive C reactive protein, mg/L
Time Frame
2 years
Title
Serum Hemoglobin, g/L
Time Frame
2 years
Title
Serum Alkaline phosphatase, U/L
Time Frame
2 years
Title
Serum Alanine aminotransferase, U/L
Time Frame
2 years
Title
Serum haptoglobin, g/L
Time Frame
2 years
Title
Plasma thyrotropin, mU/L
Time Frame
2 years
Title
serum APOE protein, mg/L
Time Frame
2 years
Title
serum brain-derived neurotrophic factor, ng/ml
Time Frame
2 years
Title
serum Fatty acids, g/100g fatty acids
Time Frame
2 years
Title
serum Carotenoids, retinol and α-tocopherol, Plasma total phenolics ng/µl
Time Frame
2 years
Title
Blood cell count
Time Frame
2 years
Title
APOE and BDNF genotype
Time Frame
baseline
Secondary Outcome Measure Information:
Title
Body mass index
Description
weight and height will be combined to report BMI in kg/m^2
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age between 40 and 60 years
overall good health (no chronic conditions e.g. mental disorders, cancer, liver or kidney disease, current or previous diagnosis),
body mass index (BMI) under 35 kg/m2,
blood pressure under 140/90 mmHg (medication allowed),
serum total cholesterol under 7.25 mmol/l (medication allowed)
fasting plasma glucose level under 7 mmol/l.
Exclusion Criteria:
Abnormal values of the alanine amino transferase, alkaline phosphatase, haptoglobin and thyroid stimulating hormone
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Raija Tahvonen, Prof
Organizational Affiliation
Natural Resources Institute Finland
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33188400
Citation
Leskinen HM, Tringham M, Karjalainen H, Iso-Touru TK, Hietaranta-Luoma HL, Marnila PJ, Pihlava JM, Hurme T, Kankaanpaa SJ, Puolijoki H, Akerman K, Tanner L, Sandell M, Vahakangas K, Hopia A, Tahvonen R, Rokka LS. APOE Genotype Disclosure and Lifestyle Advice in a Randomized Intervention Study with Finnish Participants. J Nutr. 2021 Jan 4;151(1):85-97. doi: 10.1093/jn/nxaa316.
Results Reference
derived
Learn more about this trial
Genetic Information as a Life Style Change Motivator
We'll reach out to this number within 24 hrs